TGA suspends overseas GMP inspections and QMS audits until further notice
Information for manufacturers of therapeutic goods about the suspension of all overseas GMP (Good Manufacturing Practice) inspections and QMS (Quality Management System) audits
Published
Related content
- GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemicUpdate to GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemic.
- Domestic Good Manufacturing Practice (GMP) inspections during the COVID-19 pandemicConducting domestic inspections during the Coronavirus (COVID-19) pandemic
- TGA expectations for overseas manufacturing sites hosting remote inspections during the COVID-19 pandemicInformation to assist overseas manufactures who may undergo a remote Good Manufacturing Practice inspection during the COVID-19 pandemic